| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000019727 |
| Receipt No. | R000022719 |
| Official scientific title of the study | The relation of between glucose variability and HbA1c, GA and 1,5AG in diabetes patients with insulin therapy using Continuous Glucose Monitoring system (iPro2) cross sectional study |
| Date of disclosure of the study information | 2015/11/10 |
| Last modified on | 2016/08/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The relation of between glucose variability and HbA1c, GA and 1,5AG in diabetes patients with insulin therapy using Continuous Glucose Monitoring system (iPro2)
cross sectional study |
|
| Title of the study (Brief title) | Glucose variability in diabetes patients with insulin therapy using Continuous Glucose Monitoring system (iPro2) | |
| Region |
|
|
| Condition | ||
| Condition | Diabetes mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To determine the relation of between glucose variability and HbA1c, GA and 1,5AG in diabetes patients with insulin therapy using Continuous Glucose Monitoring system (iPro2) |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Relationship between standard deviation and GA, 1.5AG |
| Key secondary outcomes | (1) The correlation between SD and HbA1c
(2) The correlation between GA, 1,5AG and the variables listed below. Mean mean amplitude of glycemic excursions (MAGE), percentage of time >180 mg/dl, >140 mg/dl, mean of daily difference of blood glucose(MODD) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Subjects who treatment with insulin for treatment of diabetes outpatients
(2)Subjects who give consent document about participation in the clinical study |
|||
| Key exclusion criteria | (1) With erythropoietin for renal anemia
(2)With anemia (Hb<10 g/dl) (3) With CKD and cirrhosis (4) With abnormal hemoglobinemia (5) With nephrotic syndrome (6)With steroid (7)With acarbose (8) hospitalized patients and discharge within two months (9) Considered as inadequate by the investigator |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yosuke Okada |
| Organization | University of Occupational and Environmental Health |
| Division name | First Department of Internal Medicine, School of Medicine |
| Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-shi 807-8555, Japan |
| TEL | +8100936031611 |
| y-okada@med.uoeh-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroko Mori |
| Organization | University of Occupational and Environmental Health |
| Division name | First Department of Internal Medicine, School of Medicine |
| Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-shi 807-8555, Japan |
| TEL | +8100936031611 |
| Homepage URL | |
| morihiro@med.uoeh-u.ac.jp | |
| Sponsor | |
| Institute | University of Occupational and Environmental Health |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Occupational and Environmental Health |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | cross sectional study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022719 |